Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to $116.3 million.

  • Sight Sciences' Liabilities and Shareholders Equity fell 1904.01% to $116.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $510.7 million, marking a year-over-year decrease of 1702.24%. This contributed to the annual value of $142.8 million for FY2024, which is 1428.85% down from last year.
  • As of Q3 2025, Sight Sciences' Liabilities and Shareholders Equity stood at $116.3 million, which was down 1904.01% from $122.0 million recorded in Q2 2025.
  • Over the past 5 years, Sight Sciences' Liabilities and Shareholders Equity peaked at $291.0 million during Q3 2021, and registered a low of $52.5 million during Q2 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $180.3 million, with a median of $171.6 million in 2023.
  • Per our database at Business Quant, Sight Sciences' Liabilities and Shareholders Equity skyrocketed by 35848.22% in 2022 and then plummeted by 2395.65% in 2023.
  • Sight Sciences' Liabilities and Shareholders Equity (Quarter) stood at $280.2 million in 2021, then decreased by 23.95% to $213.1 million in 2022, then dropped by 21.79% to $166.7 million in 2023, then decreased by 14.29% to $142.8 million in 2024, then dropped by 18.61% to $116.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $116.3 million for Q3 2025, versus $122.0 million for Q2 2025 and $129.7 million for Q1 2025.